Cited by 24

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Angiopoietin‐Like Protein 4 Is a High‐Density Lipoprotein (HDL) Component for HDL Metabolism and Function in Nondiabetic Participants and Type‐2 Diabetic Patients

Yang, Long‐Yan, Yu, Cai‐Guo, Wang, Xu‐Hong, Yuan, Sha‐Sha, Zhang, Li‐Jie, Lang, Jia‐Nan, Zhao, Dong, Feng, Ying‐Mei·2017·Journal of the American Heart Association

Abstract

Background: ANGPTL 4 (angiopoietin‐like protein 4) is a LPL (lipoprotein lipase) inhibitor and is present in high‐density lipoprotein ( HDL ). However, it is not defined whether ANGPTL 4 in HDL s could affect HDL metabolism and function in type 2 diabetes mellitus (T2 DM ). Methods and Results: ANGPTL 4 levels in the circulation and HDL s were quantified in nondiabetic participants (n=201, 68.7% females) and T2 DM patients (n=185, 66.5% females). HDL s were isolated from nondiabetic controls and T2 DM patients to assess cholesterol efflux or subjected to endothelial lipase ( EL )‐overexpressed HEK 293 cells for EL hydrolysis in vitro. The association between ANGPTL 4 in HDL s and HDL components and function was analyzed in nondiabetic participants or diabetic patients, respectively. Plasma or HDL s of ANGPTL 4+/+ and ANGPTL 4−/− mice was subjected for cholesterol efflux or EL hydrolysis, respectively. ANGPTL 4 levels in the plasma and HDL s were 1.7‐ and 2.0‐fold higher in T2 DM patients than nondiabetic controls, respectively ( P <0.0001). Multivariable analysis demonstrated that per 1 doubling increase of ANGPTL 4 levels in HDL s, the changes amounted to +0.27% cholesterol efflux ( P =0.03), +0.06 μg/mL apolipoprotein A‐I ( P =0.09) and −9.41 μg/L serum amyloid A ( P =0.02) in nondiabetic controls. In T2 DM patients, the corresponding estimates were −0.06% cholesterol efflux ( P =0.10), −0.06 μg/mL apolipoprotein A‐I ( P =0.38), and +3.64 μg/L serum amyloid A ( P =0.72). HDL s isolated from ANGPTL 4−/− mice showed accelerated hydrolysis by EL and reduced cholesterol efflux compared with ANGPTL 4+/+ littermates. Conclusions: Physically, ANGPTL 4 in HDL s protected HDL s from hydrolysis. Resulting from increased circulating ANGPTL 4 levels in T2 DM , ANGPTL 4 levels in HDL s were elevated but with compromised inhibitory effect on EL , leading to increased HDL hydrolysis and dysfunction.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/jaha.117.005973

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 37

  1. 10.1042/BSR20110102 · DOI
  2. 10.1186/s12864-015-1969-3 · DOI
  3. 10.1073/pnas.0408452102 · DOI · Paper page
  4. 10.1152/ajpendo.90345.2008 · DOI
  5. 10.1136/bmjdrc-2014-000034 · DOI
  6. 10.1074/jbc.M113.497602 · DOI · Paper page
  7. 10.1073/pnas.0604026103 · DOI · Paper page
  8. 10.1161/ATVBAHA.113.302802 · DOI
  9. 10.1161/ATVBAHA.110.212209 · DOI
  10. 10.1016/j.metabol.2008.06.016 · DOI · Paper page
  11. 10.1161/ATVBAHA.108.176917 · DOI · Paper page
  12. 10.1161/CIRCULATIONAHA.109.870709 · DOI
  13. 10.1515/hsz-2014-0192 · DOI
  14. 10.1186/s12933-016-0450-1 · DOI
  15. 10.1074/jbc.M506519200 · DOI · Paper page
  16. 10.1093/clinchem/43.11.2183 · DOI
  17. 10.7326/0003-4819-150-9-200905050-00006 · DOI · Paper page
  18. 10.1016/S0022-2275(20)35376-1 · DOI
  19. Ito Y, Oike Y, Yasunaga K, Hamada K, Miyata K, Matsumoto S, Sugano S, Tanihara H, Masuho Y, Suda T. Inhibition of angiogenesis and vascular leakiness by angiopoietin‐related protein 4. Can Res. 2003;63:6651–6657.
  20. 10.1172/JCI32057 · DOI
  21. 10.1161/ATVBAHA.115.305504 · DOI
  22. 10.1161/01.CIR.0000092889.24713.DC · DOI
  23. 10.1016/S2213-8587(14)70219-0 · DOI · Paper page
  24. 10.1016/S2213-8587(15)00126-6 · DOI
  25. 10.1161/CIRCRESAHA.116.308685 · DOI · Paper page
  26. 10.1016/j.jacc.2008.12.008 · DOI
  27. 10.1186/1471-2350-12-89 · DOI
  28. 10.1186/1475-2840-13-82 · DOI
  29. 10.1194/jlr.M002618 · DOI
  30. 10.1016/S0828-282X(06)70984-9 · DOI
  31. 10.1111/j.2040-1124.2010.00016.x · DOI
  32. 10.1073/pnas.1513872112 · DOI
  33. 10.1038/nm.3396 · DOI
  34. 10.3389/fphar.2014.00023 · DOI
  35. 10.1073/pnas.1423765112 · DOI
  36. 10.1001/jama.2013.168118 · DOI
  37. 10.1007/s11427-016-0409-7 · DOI

Cited by

Sorted by citations

Metadata

Authors
Yang, L., Yu, C., Wang, X., Yuan, S., Zhang, L., Lang, J., Zhao, D., & Feng, Y.
Affiliations
Beijing Key Laboratory of Diabetes Prevention and Research, Department of Endocrinology, Lu He Hospital, Capital Medical University, Beijing, China
Venue
Journal of the American Heart Association
Published
2017-11-06
Volume
6
Issue
6
ISSN
2047-9980
Cited by
24
References
8
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review